This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1MH Drazner , JE Rame , EK Marino , et al. (2004) Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. J Am Coll Cardiol 43, 2207–2215.
2CJ Liu , YC Cheng , KW Lee , et al. (2008) Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signalling pathway in H9c2 myocardiac cells. Mol Cell Biochem 313, 167–178.
4FR Yao , CW Sun & SK Chang (2010) Morton lentil extract attenuated angiotensin II induced cardiomyocyte hypertrophy via inhibition of intracellular reactive oxygen species levels in vitro. J Agric Food Chem 58, 10382–10388.
5E Takimoto & DA Kass (2007) Role of oxidative stress in cardiac hypertrophy and remodelling. Hypertension 49, 241–248.
6HL Li , AB Wang , Y Huang , et al. (2005) Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signalling transduction pathways. Free Rad Biol Med 38, 243–257.
7EM Alissa & GA Ferns (2012) Functional foods and nutraceuticals in the primary prevention of cardiovascular diseases. J Nutr Metabol 2012, .
8MK Ames , MK Shigenaga & TM Hagen (1993) Oxidants, antioxidants and the degenerative disease of aging. Proc Natl Acad Sci U S A 90, 7915–7922.
, et al. (2000) Primary prevention of coronary heart disease in women through diet and lifestyle. New Eng J Med
11R Srivastava , D Saluja , BS Dwarakanath , et al. (2011) Inhibition of human cervical cancer cell growth by ethanolic extract of Boerhaavia diffusa Linn. (Punarnava) root. Evid Based Complement Alternat Med 2011, .
12AS Apu , MS Liza , ATM Jamaluddin , et al. (2012) Phytochemical screening and in vitro bioactivities of the extracts of aerial part of Boerhaavia diffusa Linn. Asian Paci J Trop Biomed 2, 673–678.
13TCJ Munasinghe , CK Seneviratne , IM Thabrew , et al. (2001) Antiradical and antilipoperoxidative effects of some plant extracts used by Sri Lankan traditional medical practitioners for cardioprotection. Phytother Res 15, 519–523.
15L Pari & AM Satheesh (2004) Antidiabetic effect of Boerhaavia diffusa: effect on serum and tissue lipids in experimental diabetes. J Med Food 7, 472–476.
16KA Manu & G Kuttan (2009) Immunomodulatory activities of Punarnavine, an alkaloid from Boerhaavia diffusa. Immunopharmacol Immunotoxicol 31, 377–387.
17S Sreeja & S Sreeja (2009) An in vitro study on antiproliferative and antiestrogenic effects of Boerhaavia diffusa L. extracts. J Ethnopharmacol 126, 221–225.
18G Aviello , JM Canadanovic-Brunet , N Milic , et al. (2011) Potent antioxidant and genoprotective effects of Boeravinone G, a rotenoid isolated from Boerhaavia diffusa. Plos One 6, e19628.
19A Prathapan , MK Singh , SS Anusree , et al. (2011) Antiperoxidative, free radical scavenging and metal chelating activities of Boerhaavia diffusa L. J Food Biochem 35, 1548–1554.
20V Gulati , IH Harding & EA Palombo (2012) Enzyme inhibitory and antioxidant activities of traditional medicinal plants: potential application in the management of hyperglycemia. BMC Compl Alt Med 12, 77.
21SK Pareta , KC Patra , PM Mazumder , et al. (2011) Aqueous extract of Boerhaavia diffusa root ameliorates ethylene glycol-induced hyperoxaluric oxidative stress and renal injury in rat kidney. Pharm Biol 49, 1224–1233.
24B Hernandez-Ledesma , PJ Martin-Alvarez & E Pueyo (2003) Assessment of the spectrometric method for determination of angiotensin-converting enzyme activity: influence of the inhibition type. J Agri Food Chem 51, 4175–4179.
25PL Owen & T Johns (1999) Xanthine oxidase inhibitory activity of northeastern North American plant remedies used for gout. J Ethnopharmacol 64, 149–160.
27KE Merten , Y Jiang , W Feng , et al. (2006) Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway. J Pharmacol Exp Therap 319, 934–940.
28MM Bradford (1976) A rapid and sensitive method for the quantification of microgram quantities of protein, utilizing the principle of protein-dye binding. Anal Biochem 72, 248.
29H Aebi (1984) Catalase in vitro. Methods Enzymol 105, 121–127.
30F Paoletti , D Aldinucci , A Mocali , et al. (1986) A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts. Anal Biochem 154, 538–541.
33PJ Hissin & RA Hilf (1976) Fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74, 214–226.
34EH Choi , HJ Chang , JY Cho , et al. (2007) Cytoprotective effect of anthocyanins against doxorubicin-induced toxicity in H9c2 cardiomyocytes in relation to their antioxidant activities. Food Chem Toxicol 45, 1873–1881.
35KG Raghu & OL Cherian (2009) Characterization of cytotoxicity induced by arsenic trioxide (a potent anti-APL drug) in rat cardiac myocytes. J Trace Elem Med Biol 23, 61–68.
36P Chomczynski & N Sacchi (1987) Singlet-step method of RNA isolation by acid guanidium thiocyanate–phenol–chloroform extraction. Anal Biochem 162, 156–159.
37BW Kimes & BL Brandt (1976) Properties of a clonal muscle cell line from rat heart. Exp Cell Res 98, 367–381.
38SJ Watkins , GM Borthwick & HM Arthur (2011) The H9c2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In vitro Cell Dev Biol Animal 47, 125–131.
39J Hescheler , R Meyer , S Plant , et al. (1991) Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ Res 69, 1476–1486.
40KR Sipido & E Marban (1991) L-type calcium channels, potassium channels, and novel nonspecific cation channels in a clonal muscle cell line derived from embryonic rat ventricle. Circ Res 69, 1487–1499.
41KC Wollert & H Drexler (1999) The rennin–angiotensin system and experimental heart failure. Cardiovasc Res 43, 838–849.
42T Unger (2002) The role of the renin–angiotensin system in the development of cardiovascular disease. Am J Cardiol 89, 3A–9A.
43H Wang & JA Joseph (1999) Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Rad Biol Med 27, 612–616.
(2006) Xanthine oxidase inhibition and heart failure. Circ Res
45B Poljsak (2011) Strategies for reducing or preventing the generation of oxidative stress. Oxid Med Cell Longev 2011, 194586.
46D Dinu , GO Bodea , CD Ceapa , et al. (2011) Adapted response of the antioxidant defense system to oxidative stress induced by deoxynivalenol in Hek-293 cells. Toxicon 57, 1027–1032.
48SK Nelson , SK Bose & JM McCord (1994) The toxicity of high-dose superoxide dismutase suggests that superoxide can both initiate and terminate lipid peroxidation in the reperfused heart. Free Radic Biol Med 16, 195–200.
49M Shlafer & BM Shepard (1984) A method to reduce interference by sucrose in the detection of thiobarbituric acid-reactive substances. Anal Biochem 137, 269–276.
(1996) Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res
(2002) Induction of cellular glutathione linked enzymes and catalase by the unique chemo preventive agent, 3H-1,2-dithiole-3-thione in rat cardiomyocytes affords protection against oxidative cell injury. Pharmacol Res
52PA Abhilash , R Harikrishnan & M Indira (2012) Ascorbic acid supplementation causes faster restoration of reduced glutathione content in the regression of alcohol induced hepatotoxicity in male guinea pigs. Redox Rep 17, 72–79.
(2003) Effect of whey protein isolate on intracellular glutathione and oxidant-induced cell death in human prostate epithelial cells. Toxicol in vitro
54X Ouyang , K Takahashi , K Komatsu , et al. (2001) Protective effect of Salvia militiorrhiza on angiotensin II induced hypertrophic responses in neonatal rat cardiac cells. Jpn J Pharmacol 87, 289–296.
55H Ichikawa , H Yagi , T Tanaka , et al. (2010) Lagerstroemia speciosa extract inhibit TNF-induced activation of nuclear factor-κβ in rat cardiomyocyte H9c2 cells. J Ethnopharmacol 128, 254–256.
56NH Purcell , G Tang , C Yu , et al. (2001) Activation of NF-κβ is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci U S A 98, 6668–6673.
57Y Li , T Ha , X Gao , et al. (2004) NF-κB activation is required for the development of cardiac hypertrophy in vivo. Am J Physiol Heart Circ Physiol 287, 1712–1720.
(1996) The NF-kappa B and I-kappa B proteins: new discoveries and insights. Ann Rev Immunol
, et al. (2005) NF κβ in cardiovascular disease. Cardiovasc Toxicol
60RK Li , G Li , DA Mickle , et al. (1997) Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. Circulation 96, 874–881.
61JJ Schultz , SA Witt , BJ Glascock , et al. (2002) TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J Clin Invest 109, 787–796.
62T Yamazaki , N Yamashita , Y Izumi , et al. (2012) The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice. Hypertension Res 35, 34–40.
64F Ferreres , C Sousa , M Justin , et al. (2005) Characterization of phenolic profile of Boerhaavia diffusa L. by HPLC-PAD-MS/MS as tool for quality control. Phytochem Anal 16, 451–458.
66F Perez-Vizcaino & J Duarte (2010) Flavonols and cardiovascular disease. Mol Aspects Med 31, 478–494.
67J Duarte , R Jimenez , F O'Valle , et al. (2002) Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. J Hypertens 20, 1843–1854.
68JM Calderon-Montano , E Burgos-Moron , C Perez-Guerrero , et al. (2011) A review on the dietary flavonoid kaempferol. Mini Rev Med Chem 11, 298–344.
(2007) Protective effect of ursolic acid against myocardial ischemia induced by isoproterenol in rats. Toxicol Mech Methods
70N Lami , S Kadota , T Kikuchi , et al. (1991) Constituents of the roots of Boerhaavia diffusa L. III. Identification of a calcium channel antagonistic compound from the methanol extract. Chem Pharm Bull 39, 1551–1555.